Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
When does linzess go off patent?Valsartan price philippines?Macl vs lupin levothyroxine?Zytiga 500 mg price in usa?Ilumya injection cost?
See the DrugPatentWatch profile for Miebo
The NDC for Miebo is 00071-2001-10 [1]. Miebo is an ophthalmic solution used to treat the signs and symptoms of dry eye disease [1]. Its active ingredient is perfluorohexyloctane [1].
Miebo's active ingredient is perfluorohexyloctane [1].
Miebo is administered as an ophthalmic solution [1].
Miebo is used to treat the signs and symptoms associated with dry eye disease [1].
Other Questions About Miebo :